High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure

American Journal of Transplantation

Volumn 4, Issue 9, 2004, Pages 1466-1474

  Rotondi, Mario ^a   Rosati, Alberto ^b   Buonamano, Andrea ^a   Lasagni, Laura ^a   Lazzeri, Elena ^a   Pradella, Fabio ^c   Fossombroni, Vittorio ^c   Cirami, Calogero ^b   Liotta, Francesco ^a   La Villa, Giorgio ^a   Serio, Mario ^a   Bertoni, Elisabetta ^b   Salvadori, Maurizio ^b   Romagnani, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Ctr Nephrol Dialysis/Transplant   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

CXCR3; Graft failure; Graft outcome; IP 10; Rejection

Indexed keywords

C REACTIVE PROTEIN; CCL22 CHEMOKINE; CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CADAVER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CHEMOKINES, CXC; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 4344648638     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00525.x     Document Type: Article

References (47)

1. Stepkowski SM. Immunobiology of allograft rejection. In: Kahan BD, Ponticelli C, eds. Principles and Practice in Renal Transplantation. London: Martin Dunitz Ltd, 2000: 41-87.
2. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217-242.
3. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-134.
4. Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963-969.
5. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med 2001; 194: 1375-1384.
6. Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001; 167: 1862-1866.
7. Romagnani P, Annunziato F, Lazzeri E et al. Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in human thymus. Blood 2001; 97: 601-607.
8. Wang X, Yue TL, Ohlstein EH, Sung CP, Feuerstein GZ. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem 1996; 271: 24286-24293.
9. Romagnani P, Beltrame C, Annunziato F et al. Role for interactions between IP-10/Mig and their receptor (CXCR3) in proliferative glomerulonephritis. J Am Soc Nephrol 1999; 10: 2518-2526.
10. Romagnani P, Lazzeri E, Lasagni L et al. IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 2002; 13: 53-64.
11. Bonacchi A, Romagnani P, Romanelli RG et al. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 2001; 276: 9945-9954.
12. Romagnani P, Annunziato F, Lasagni L et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 2001; 107: 53-63.
13. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S. CXC chemokines the regulatory link between inflammation and angiogenesis. Trends Immunol 2004; 25: 201-209.
14. Lazzeri E, Romagnani P. CXCR3-binding chemokines: multifaceted therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord 2004, in press.
15. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001; 193: 975.
16. Hancock WW, Lu B, Gao W et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000; 192: 1515-1519.
17. Zhang Z, Kaptanoglu L, Haddad W et al. Donor T Cell Activation Initiates Small Bowel Allograft Rejection Through ah IFN-γ-Inducible Protein-10-Dependent Mechanism. J Immunol 2002; 168: 3205-3212.
18. Segerer S, Cui Y, Eitner F et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518-531.
19. Agostini C, Calabrese F, Rea F et al. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158: 1703-1711.
20. Melter M, Exeni A, Reinders ME et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001; 104: 2558-2564.
21. Fahmy NM, Yamani MH, Starling RC et al. Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation 2003; 75: 72-78.
22. Zhao DX, Hu Y, Miller GG, Luster AD, Mitchell RN, Libby P. Differential Expression of the IFN-{gamma}-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell {alpha} Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection. J Immunol 2002; 169: 1556-1560.
23. Akalin E, Dikman S, Murphy B, Bromberg JS, Hancock WW. Glomerular Infiltration by CXCR3+ ICOS+ Activated T Cells in Chronic Allograft Nephropathy with Transplant Glomerulopathy. Am J Transplant 2003; 3: 1116-1120.
24. Romagnani P, Rotondi M, Lazzeri E et al. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 2002; 161: 195-206.
25. Bonecchi R, Sozzani S, Stine JT et al. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998; 92: 2668-2671.
26. Galli G, Chantry D, Annunziato F et al. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur J Immunol 2000; 30: 204-210.
27. Rotondi M, Lazzeri E, Romagnani P, Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 2003; 26: 177-180.
28. Hancock WW, Wang L, YeQ. Han R, Lee I. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003; 15: 479-486.
29. Solez K, Benediktsson H, Cavallo T et al. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996; 28: 441-444.
30. Gourishankar S, Halloran PF. Late deterioration of organ transplants. a problem in injury and homeostasis. Curr Opin Immunol 2002; 14: 576-583.
31. Süsal C, Pelzl S, Döhler B, Opelz G. for the Collaborative Transplant Study. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002; 13: 1650-1656.
32. Campbell JD, Gangur V, Simons FE, HayGlass KT. Allergic humans are hyporesponsive to a CXCR3-ligand-mediated Th1 immunity-promoting loop. Faseb J 2004; 18: 329-331.
33. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10) -deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168: 3195-3204.
34. Lasagni L, Francalanci M, Annunziato F et al. An alternatively spliced variant of CXCR3 mediates the IP-10, Mig and I-TAC induced-inhibition of endothelial cell growth and acts as functional receptor for PF-4. J Exp Med 2003; 197: 1537-1549.
35. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-lbeta, TNF-alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994; 45: 890-896.
36. Pecoits-Filho R, Heimburger O, Barany P et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218.
37. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557.
38. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001; 78: S206-S211.
39. Sester U, Sester M, Hauk M, Kaul H, Kohler H, Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 1217-1223.
40. Perez RV, Brown DJ, Katznelson SA et al. Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation 2000; 69: 869-874.
41. Fink JC, Onuigbo MA, Blahut SA et al. Pretransplant serum Creactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. Am J Kidney Dis 2002; 39: 1096-1101.
42. Lauzurica R, Pastor C, Bayes B et al. High-sensitivity C-reactive protein as pretransplant marker for acute rejection and cardiovascular morbidity. Transplant Proc 2002; 34: 392-393.
43. Varagunam M, Finney H, Trevitt R, Sharples E, McCloskey DJ, Sinnott PJ. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 2004; 43: 502-507.
44. Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ. Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant 2004; 4: 432-437.
45. Kao J, Kobashigawa J, Fishbein MC et al. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease. Circulation 2003; 107: 1958-1961.
46. Beaudeux JL, Dorent R, Bernard M et al. Circulating monocyte chemoattractant protein-1 in heart transplant recipients with cardiac allograft vasculopathy. Clin Biochem 2002; 35: 77-79.
47. Hricik DE, Rodriguez V, Riley J et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003; 3: 878-884.